Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice.
The promoter effect of medroxyprogesterone acetate (MPA) on mammary carcinogenesis in female BALB/c mice was investigated using methylnitrosourea (MNU) as initiator. Nine out of 43 animals developed mammary carcinomas in the group treated with MNU (50 mg/kg) and MPA (administration of 40 mg every 3 months) starting 1 week after MNU administration. No tumors appeared in controls receiving only MNU or MPA during the time course of the experiment (9 months). The tumors were lobular adenocarcinomas showing different degrees of squamous differentiation with low or undetectable estrogen and progesterone receptors, and expressing epidermal growth factor receptors. These results support the hypothesis that MPA promotes the growth of MNU induced lesions.
Pazos
P
P
Instituto de Biologia y Medicina Experimental, Academia Nacional de Medicina, Buenos Aires, Argentina.
Lanari
C
C
Elizalde
P
P
Montecchia
F
F
Charreau
E H
EH
Molinolo
A A
AA
D000230:Adenocarcinoma / Q000139:chemically induced*; D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D003043:Cocarcinogenesis; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced*; D017258:Medroxyprogesterone Acetate / Q000633:toxicity*; D008770:Methylnitrosourea / Q000633:toxicity*; D051379:Mice; D008807:Mice, Inbred BALB C
D002273:Carcinogens; D008770:Methylnitrosourea; D017258:Medroxyprogesterone Acetate